Correlation Between Inhibrx and Verona Pharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Verona Pharma PLC, you can compare the effects of market volatilities on Inhibrx and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Verona Pharma.
Diversification Opportunities for Inhibrx and Verona Pharma
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inhibrx and Verona is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Inhibrx i.e., Inhibrx and Verona Pharma go up and down completely randomly.
Pair Corralation between Inhibrx and Verona Pharma
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Verona Pharma. In addition to that, Inhibrx is 1.33 times more volatile than Verona Pharma PLC. It trades about -0.01 of its total potential returns per unit of risk. Verona Pharma PLC is currently generating about 0.13 per unit of volatility. If you would invest 1,367 in Verona Pharma PLC on September 2, 2024 and sell it today you would earn a total of 2,596 from holding Verona Pharma PLC or generate 189.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Verona Pharma PLC
Performance |
| Timeline |
| Inhibrx |
| Verona Pharma PLC |
Inhibrx and Verona Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Verona Pharma
The main advantage of trading using opposite Inhibrx and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Verona Pharma vs. Ventyx Biosciences | Verona Pharma vs. Ideaya Biosciences | Verona Pharma vs. Protagonist Therapeutics | Verona Pharma vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |